New Results
Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer
Marco Barreca, Matteo Dugo, Barbara Galbardi, Balázs Győrffy, NA-PHER2 consortium, NeoTRIP consortium, Pinuccia Valagussa, Daniela Besozzi, Giuseppe Viale, Giampaolo Bianchini, Luca Gianni, Maurizio Callari
doi: https://doi.org/10.1101/2024.02.23.581701
Marco Barreca
1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy
2Michelangelo Foundation, Milan, Italy
Matteo Dugo
3IRCCS San Raffaele Hospital, Milan, Italy
Barbara Galbardi
3IRCCS San Raffaele Hospital, Milan, Italy
Balázs Győrffy
4Department of Bioinformatics, Semmelweis University, H-1094, Budapest, Hungary
5Department of Biophysics, Medical School, University of Pecs, H-7624, Pecs, Hungary
6Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Research Centre for Natural Sciences, H-1117, Budapest, Hungary
Pinuccia Valagussa
2Michelangelo Foundation, Milan, Italy
Daniela Besozzi
7Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy
8Bicocca Bioinformatics, Biostatistics and Bioimaging (B4) Research Centre, Milan, Italy
Giuseppe Viale
9European Institute of Oncology, Milan, Italy
Giampaolo Bianchini
3IRCCS San Raffaele Hospital, Milan, Italy
10UniSR San Raffaele University, Milan, Italy
Luca Gianni
2Michelangelo Foundation, Milan, Italy
Maurizio Callari
2Michelangelo Foundation, Milan, Italy
Article usage
Posted February 27, 2024.
Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer
Marco Barreca, Matteo Dugo, Barbara Galbardi, Balázs Győrffy, NA-PHER2 consortium, NeoTRIP consortium, Pinuccia Valagussa, Daniela Besozzi, Giuseppe Viale, Giampaolo Bianchini, Luca Gianni, Maurizio Callari
bioRxiv 2024.02.23.581701; doi: https://doi.org/10.1101/2024.02.23.581701
Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer
Marco Barreca, Matteo Dugo, Barbara Galbardi, Balázs Győrffy, NA-PHER2 consortium, NeoTRIP consortium, Pinuccia Valagussa, Daniela Besozzi, Giuseppe Viale, Giampaolo Bianchini, Luca Gianni, Maurizio Callari
bioRxiv 2024.02.23.581701; doi: https://doi.org/10.1101/2024.02.23.581701
Subject Area
Subject Areas
- Biochemistry (12806)
- Bioengineering (9690)
- Bioinformatics (31296)
- Biophysics (16118)
- Cancer Biology (13197)
- Cell Biology (18873)
- Clinical Trials (138)
- Developmental Biology (10219)
- Ecology (15201)
- Epidemiology (2067)
- Evolutionary Biology (19419)
- Genetics (12890)
- Genomics (17789)
- Immunology (12921)
- Microbiology (30225)
- Molecular Biology (12617)
- Neuroscience (65996)
- Paleontology (487)
- Pathology (2042)
- Pharmacology and Toxicology (3519)
- Physiology (5455)
- Plant Biology (11310)
- Synthetic Biology (3124)
- Systems Biology (7772)
- Zoology (1758)